CAS 140128-16-1 | CEFMA-006 : Cefmatilen hydrochloride hydrate
(World's Largest Pharmaceutical Supplier)

CAS 140128-16-1 is a chemical compound known as dulaglutide. It is a medication that belongs to the class of glucagon-like peptide-1 receptor agonists (GLP-1 RA) and is primarily used in the treatment of type 2 diabetes mellitus.

Dulaglutide is a synthetic form of a hormone called glucagon-like peptide-1 (GLP-1), which is naturally produced in the body. Its chemical formula is C264H404N72O78S6, and it is available as an injectable solution for subcutaneous administration.

One of the main uses of CAS 140128-16-1 is to help control blood sugar levels in individuals with type 2 diabetes. Dulaglutide works by stimulating the release of insulin from pancreatic beta cells when blood sugar levels are high and by reducing the production of glucagon, a hormone that increases blood sugar levels. These actions help lower blood glucose levels and improve glycemic control.

Additionally, dulaglutide has been found to have other beneficial effects beyond glucose control. It promotes weight loss by increasing feelings of fullness and reducing appetite. It also slows down the emptying of food from the stomach, leading to improved satiety and reduced caloric intake. As a result, it can be prescribed for weight management in individuals with obesity or overweight who have related health conditions.

Moreover, dulaglutide has shown potential in reducing the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular diseases. Clinical studies have demonstrated its efficacy in lowering the risk of heart attack, stroke, and cardiovascular death when used as part of comprehensive cardiovascular risk management.

It is important to note that dulaglutide should be used under medical supervision, and dosage adjustments may be necessary based on individual patient factors. Common side effects may include nausea, vomiting, diarrhea, and decreased appetite. Rare but serious side effects, such as pancreatitis and thyroid tumors, have been reported and should be monitored by healthcare professionals.

In conclusion, CAS 140128-16-1, or dulaglutide, is a medication used in the treatment of type 2 diabetes mellitus. It helps control blood sugar levels, promotes weight loss, and has potential cardiovascular benefits. However, it should be used under medical supervision, and patients should be aware of potential side effects. Regular monitoring and adherence to a comprehensive diabetes management plan are essential for optimal outcomes.